COCH: Envoy Medical Inc - Class A

COCH新闻

• 12:37 Envoy Medical Surpasses 6-Month Follow-Up Visit Milestone For Pivotal Clinical Trial Evaluating Investigational Fully Implanted Acclaim Cochlear Implant; Expects To Submit Final Clinical PMA Module By End Of Q2 2027
• 12:33 Envoy Medical 提交其 Acclaim 人工耳蜗 PMA 申请的第二个 FDA 模块；目标于 2027 年第二季度提交最终临床资料
• 12:33 Envoy Medical Submits Second FDA Module Of Its PMA Application For The Acclaim Cochlear Implant; Targets Final Clinical Submission In Q2 2027
• 13:06 Envoy Medical Announces Delaware Chancery Court Dismissal With Prejudice Of Atlas Merchant Capital Spac Fund I's Claim That It Was Not Allowed To Redeem Shares
• 19:56 Lake Street开始覆盖Envoy Medical，给予买入评级，并宣布目标价为2.5美元
• 19:56 Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5
• 12:35 Envoy Medical Granted Two Additional Global Patents Over Its IP Portfolio
• 12:35 恩沃伊医疗获得其知识产权组合的两项全球专利
• 13:40 Are Medical Stocks Lagging Compugen (CGEN) This Year?
• 13:45 Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates
• 14:00 Waters (WAT) Earnings Expected to Grow: Should You Buy?
• 14:00 Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
• 13:40 Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?
• 11:15 AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates
• 22:05 TransMedics (TMDX) Q1 Earnings and Revenues Miss Estimates